within Pharmacolibrary.Drugs.R_RespiratorySystem.R03C_AdrenergicsForSystemicUse.R03CB53_OrciprenalineCombinations;

model OrciprenalineCombinations
  extends Pharmacolibrary.Drugs.ATC.R.R03CB53;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R03CB53</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Orciprenaline, also known as metaproterenol, is a beta-2 adrenergic agonist used primarily as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). The ATC code R03CB53 refers to combinations of orciprenaline with other drugs. Use of orciprenaline as a single agent or in combinations has significantly declined in many countries due to the availability of newer and more selective agents, and in some regions it is no longer approved.</p><h4>Pharmacokinetics</h4><p>No peer-reviewed, population-specific pharmacokinetic data for orciprenaline in combinations under ATC R03CB53 has been found in the scientific literature. The following values are generalized estimates based on available data for single-agent orciprenaline oral administration in healthy adults.</p><h4>References</h4><ol><li><p>Hageman, RJ, et al., &amp; Koëter, GH (1988). Plasma levels, heart rate, and blood pressure after intravenous, oral, and aerosol administration of reproterol in man. <i>Biopharmaceutics &amp; drug disposition</i> 9(3) 301–314. DOI:<a href=\"https://doi.org/10.1002/bod.2510090308\">10.1002/bod.2510090308</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3395671/\">https://pubmed.ncbi.nlm.nih.gov/3395671</a></p></li><li><p>Kucharczyk, N, et al., &amp; Sofia, RD (1981). Biotransformation of reproterol in the intestinal tract of the rat. <i>Arzneimittel-Forschung</i> 31(12) 2085–2088. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7199302/\">https://pubmed.ncbi.nlm.nih.gov/7199302</a></p></li><li><p>Knebel, NG, &amp; Winkler, M (1997). Rapid and automated determination of the beta2-agonist reproterol in human plasma by atmospheric pressure chemical ionisation high-performance liquid chromatography-tandem mass spectrometry. <i>Journal of chromatography. B, Biomedical sciences and applications</i> 702(1-2) 119–129. DOI:<a href=\"https://doi.org/10.1016/s0378-4347(97)00381-2\">10.1016/s0378-4347(97)00381-2</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9449563/\">https://pubmed.ncbi.nlm.nih.gov/9449563</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end OrciprenalineCombinations;
